← All candidates
62 insider filings on record.
62 filings on record.
ABEOABEONA THERAPEUTICS INC.
NasdaqCM · Healthcare · $322.52M
$5.57
-0.36% · Sep 18
62 insider filings on record.
None of them an open-market buy in the last year.
Price · 1Y · daily● 34 sells
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
Reverse-split 5×. When a company does a reverse split, the chart rewrites its old prices to look far bigger than they really were — so the high early prices here aren't what ABEO ever actually traded at. The drop is real, but those huge old numbers aren't.
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$322.52M
Float
36.8M
64% public
Short % float
Pro
Price / profit
7.6
Price / future profit
—
Price / sales
12.6
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
57 more transactions on Pro →Context
Wall St
$19.71 avg target
+253.9% vs today · 7 analysts · consensus Strong Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
3 of 4 quarters beat
Q1 '26−$0.30 act+$0.09
Q4 '25−$0.37 act+$0.01
Q3 '25−$0.11 act+$0.24
Q2 '25−$0.47 act−$0.07
Coverage
Abeona Therapeutics Inc (ABEO) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and ...GuruFocus.com · 05-13Abeona Therapeutics Q1 Earnings Call HighlightsMarketBeat · 05-13Abeona Therapeutics Q1 2026 Earnings Call: Complete TranscriptBenzinga · 05-13Spotlighting Abeona Therapeutics And 2 More High Growth Stocks Insiders FavorSimply Wall St. · 04-21
The file stays open
62 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice